It’s well-known that clinical trials are one of the most expensive parts of the drug development process. Addressable bottlenecks include improving access to knowledge for protocol design such as appropriate biomarkers, clinical outcomes, eligibility criteria, assessment schedules, and more.
June 30, 2022 | 8:30-9:30PM GMT+
Physicians’ Education Resource® (PER®) presents the 6th Annual Live Medical Crossfire®: Hematologic Malignancies—a 1-day Medical Crossfire® designed to interactively explore the most controversial clinical issues in the field of hematologic malignancies through live, interactive panel discussions with renowned experts. This meeting will contrast viewpoints of key opinion leaders across the country […]